Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia
- Irene M. Ghobrial
- , Aldo Roccaro
- , Fangxin Hong
- , Edie Weller
- , Nancy Rubin
- , Renee Leduc
- , Meghan Rourke
- , Stacey Chuma
- , Antonio Sacco
- , Xiaoying Jia
- , Feda Azab
- , Abdel Kareem Azab
- , Scott Rodig
- , Diane Warren
- , Brianna Harris
- , Lyuba Varticovski
- , Peter Sportelli
- , Xavier Leleu
- , Kenneth C. Anderson
- , Paul G. Richardson
Research output: Contribution to journal › Article › peer-review
105
Link opens in a new tab
Scopus
citations